Clinical Trial Update: PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating PS101-mediated adoptive cell therapy with chemotherapy for liver metastases from gastrointestinal cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PS101-mediated adoptive cell therapy (PS101 ACT)

Snippet

Sponsor: EXACT Therapeutics AS | Conditions: Solid Tumor, Colorectal Cancer | Phase 1 | Status: TERMINATED